What Is The Long-term Outlook for AMC Stock?
Meme stock extraordinaire AMC Entertainment Holdings, Inc. (NYSE:AMC) has long…
Sell
37
ACA Quote, Financials, Valuation and Earnings
Last price:
$86.94
Seasonality move
:
4.54%
Day range:
$85.56 - $88.14
52-week range:
$68.11 - $113.43
Dividend yield:
0.23%
P/E ratio:
53.87x
P/S ratio:
1.61x
P/B ratio:
1.70x
Volume:
407.3K
Avg. volume:
226.3K
1-year change:
3.37%
Market cap:
$4.2B
Revenue:
$2.6B
EPS (TTM):
$1.59
Analysts' Opinion
-
Consensus RatingArcosa has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $111.83, Arcosa has an estimated upside of 30.57% from its current price of $85.65.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $100.00 representing 100% downside risk from its current price of $85.65.
Fair Value
-
According to the consensus of 5 analysts, Arcosa has 30.57% upside to fair value with a price target of $111.83 per share.
ACA vs. S&P 500
-
Over the past 5 trading days, Arcosa has underperformed the S&P 500 by -3.18% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Arcosa does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Arcosa has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Arcosa reported revenues of $632M.
Earnings Growth
-
Arcosa earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Arcosa reported earnings per share of $0.48.
Enterprise value:
5.7B
EV / Invested capital:
1.38x
Price / LTM sales:
1.61x
EV / EBIT:
28.10x
EV / Revenue:
2.19x
PEG ratio (5yr expected):
0.08x
EV / Free cash flow:
22.66x
Price / Operating cash flow:
16.67x
Enterprise value / EBITDA:
13.95x
Gross Profit (TTM):
$529M
Return On Assets:
1.8%
Net Income Margin (TTM):
3%
Return On Equity:
3.23%
Return On Invested Capital:
2.17%
Operating Margin:
8.18%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $2.3B | $2.4B | $2.6B | $598.6M | $632M | |
| Gross Profit | $423.6M | $446.8M | $529M | $111.6M | $125.4M | |
| Operating Income | $160.9M | $179.1M | $204.4M | $42.5M | $51.7M | |
| EBITDA | $545.5M | $366.1M | $408.6M | $98.4M | $111.1M | |
| Diluted EPS | $5.77 | $2.92 | $1.59 | $0.80 | $0.48 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $697.8M | $841.6M | $912.9M | $993.7M | $1B | |
| Total Assets | $2.7B | $3.3B | $3.4B | $3.7B | $4.9B | |
| Current Liabilities | $312.2M | $403.7M | $380.4M | $434.9M | $510M | |
| Total Liabilities | $754.7M | $1.3B | $1.2B | $1.3B | $2.5B | |
| Total Equity | $1.9B | $2B | $2.2B | $2.4B | $2.5B | |
| Total Debt | $255.9M | $680.6M | $549.9M | $607.2M | $1.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $177.1M | $314.2M | $420.8M | $80.5M | -$700K | |
| Cash From Investing | $61.9M | -$295.2M | -$1.5B | -$43.5M | -$11.4M | |
| Cash From Financing | -$178.4M | $8.3M | $1B | $34.7M | -$7.3M | |
| Free Cash Flow | $20.6M | $100.7M | $251.5M | $26.1M | -$34.7M | |
ACA
Sector
Market Cap
$4.2B
$618.1M
Price % of 52-Week High
75.51%
79.17%
Dividend Yield
0.23%
0%
Shareholder Yield
-5.39%
2.29%
1-Year Price Total Return
3.37%
-0.22%
Beta (5-Year)
1.009
0.778
Dividend yield:
0.23%
Annualized payout:
$0.20
Payout ratio:
12.55%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$86.29
200-day SMA
Sell
Level
$91.94
Bollinger Bands (100)
Sell
Level
78.1 - 93.98
Chaikin Money Flow
Buy
Level
10.7M
20-day SMA
Sell
Level
$87.32
Relative Strength Index (RSI14)
Sell
Level
47.03
ADX Line
Sell
Level
14.19
Williams %R
Neutral
Level
-77.0865
50-day SMA
Buy
Level
$84.87
MACD (12, 26)
Buy
Level
0.22
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
26M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.1162)
Buy
CA Score
(Annual)
Level (0.2631)
Buy
Beneish M-Score
(Annual)
Level (-3.2284)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (0.0377)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.
Stock Forecast FAQ
In the current month, ACA has received 5 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ACA average analyst price target in the past 3 months is $111.83.
-
Where Will Arcosa Stock Be In 1 Year?
According to analysts, the consensus estimate is that Arcosa share price will rise to $111.83 per share over the next 12 months.
-
What Do Analysts Say About Arcosa?
Analysts are divided on their view about Arcosa share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Arcosa is a Sell and believe this share price will drop from its current level to $100.00.
-
What Is Arcosa's Price Target?
The price target for Arcosa over the next 1-year time period is forecast to be $111.83 according to 5 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ACA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Arcosa is a Buy. 5 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ACA?
You can purchase shares of Arcosa via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Arcosa shares.
-
What Is The Arcosa Share Price Today?
Arcosa was last trading at $86.94 per share. This represents the most recent stock quote for Arcosa. Yesterday, Arcosa closed at $85.65 per share.
-
How To Buy Arcosa Stock Online?
In order to purchase Arcosa stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NuScale the Best Nuclear Stock to Buy?
NuScale Power (NYSE:SMR) is a nuclear power startup that has…
Where Will Kestra Medical Stock Be in 1 Year?
Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 52x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 42x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
76
AVAV alert for Jun 26
AeroVironment [AVAV] is up 12.8% over the past day.
Buy
59
NKTR alert for Jun 26
Nektar Therapeutics [NKTR] is down 1.79% over the past day.
Buy
51
SITM alert for Jun 26
SiTime [SITM] is up 1.5% over the past day.
